207 related articles for article (PubMed ID: 21605993)
1. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
2. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
[TBL] [Abstract][Full Text] [Related]
3. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
4. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
5. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
[TBL] [Abstract][Full Text] [Related]
6. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
8. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
[TBL] [Abstract][Full Text] [Related]
9. Electrostatic exploration of the C3d-FH4 interaction using a computational alanine scan.
El-Assaad AM; Kieslich CA; Gorham RD; Morikis D
Mol Immunol; 2011 Sep; 48(15-16):1844-50. PubMed ID: 21683447
[TBL] [Abstract][Full Text] [Related]
10. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
[TBL] [Abstract][Full Text] [Related]
11. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.
Morgan HP; Jiang J; Herbert AP; Kavanagh D; Uhrin D; Barlow PN; Hannan JP
Acta Crystallogr D Biol Crystallogr; 2011 Jul; 67(Pt 7):593-600. PubMed ID: 21697597
[TBL] [Abstract][Full Text] [Related]
12. Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex.
E S Harrison R; Gorham RD; Morikis D
Protein Sci; 2015 May; 24(5):789-802. PubMed ID: 25628052
[TBL] [Abstract][Full Text] [Related]
13. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
14. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
15. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
[TBL] [Abstract][Full Text] [Related]
16. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
[TBL] [Abstract][Full Text] [Related]
17. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.
Pechtl IC; Kavanagh D; McIntosh N; Harris CL; Barlow PN
J Biol Chem; 2011 Apr; 286(13):11082-90. PubMed ID: 21270465
[TBL] [Abstract][Full Text] [Related]
18. Multiple interactions of complement Factor H with its ligands in solution: a progress report.
Perkins SJ; Nan R; Okemefuna AI; Li K; Khan S; Miller A
Adv Exp Med Biol; 2010; 703():25-47. PubMed ID: 20711705
[TBL] [Abstract][Full Text] [Related]
19. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of the product of disease-related factor H gene conversion.
Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
